Business

Vyome Holdings Merges with ReShape Lifesciences, Debuts as 'Hind' on Nasdaq

Vyome Holdings Marks Historic Nasdaq Debut as 'Hind'

In a landmark event coinciding with India's 79th Independence Day, Vyome Holdings, formed through the merger of biotech startup Vyome Therapeutics and Nasdaq-listed ReShape Lifesciences, began trading under the ticker 'Hind'. Vyome shareholders now hold a commanding 91.6% stake in the newly combined entity.

Vyome Holdings lists as Hind on Nasdaq

Stay updated with the latest in business news, including bank and public holidays, and current rates for gold and silver.